Pardon our appearance while we renovate our website. The process may take up to a month and we respectfully request that any papers be submitted after that date. We will post a notice when the site is reopened. The Editorial staff at ePlasty thanks you for your patience and support.
Terms of use | Privacy Policy Home | Contact Us

<< Back
Print E-mail
ePlasty: Vol. 16
Management of Lumbosacral Myelomeningocele
Peter M. DeJong, BS,a Nicholas S. Adams, MD,a,b Robert J. Mann, MD,a,b,c John W. Polley, MD,a,b,c and John A. Girotto, MD, MMAa,b,c

aMichigan State University College of Human Medicine, Grand Rapids, Mich; bPlastic and Reconstructive Surgery Residency, Grand Rapids Medical Education Partners, Grand Rapids, Mich; and cPediatric Plastic and Craniofacial Surgery, Helen DeVos Children's Hospital, Grand Rapids, Mich

Correspondence: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Keywords: myelomeningocele, spina bifida, paraspinal fascial turnover flap, neural tube defect, fascial flap


A newborn female patient presented with a prenatally diagnosed lumbosacral myelomeningocele (MMC) (Figs 1a and 1b). Four hours after cesarean delivery, the child was taken for neurosurgical repair. Plastic Surgery was consulted for soft-tissue closure.

Figure 1. (a, b) Preoperative posterior and lateral photographs demonstrating the lumbosacral myelomeningocele prior to neurosurgical repair and soft-tissue coverage.


1. Discuss the embryology of neural tube closure.

2. What are neural tube defects (NTDs)?

3. What are the risk factors for developing NTDs?

4. What techniques have been described for soft-tissue coverage of MMC?


Neural tube closure occurs early in human development as part of primary neurulation. It is completed between the third and fourth weeks of embryonic development. The neural plate, derived from neuroectodermal cells or neural crest cells, forms the neural groove during week 3. Progressive bending of the groove leads to the eventual fusion of the resulting neural folds. Beginning at the level of the fifth somite, near the future convergence of the spinal cord and hindbrain, the resultant cranial and caudal neuropores close bidirectionally in a zipper-like fashion (Fig 2). Cranial neuropore closure is completed by day 25, whereas the caudal neuropore closes on day 28.1 Successful completion of this closure requires the precise coordination of cellular genetic regulation, molecular processes, and the physical forces they generate.2

Figure 2. Neural tube closure. Neural tube closure progressing in a zipper-like fashion starting centrally and moving cranial and caudal (left and center). Failure of caudal neuropore closure results in myelomeningocele (right).

NTDs arise from failed migration of neural crest cells. Because the cranial and caudal ends of the neural tube are the last to close, disruptions in neural crest cell migration will lead to varying degrees and varying locations of defects. Failure of cranial closure will lead to exencephaly/anencephaly, a fatal condition.2 Failure of caudal neuropore closure leads to open defects such as meningocele and MMC or spina bifida cystica (Fig 2). MMC is the most common NTD that is compatible with life, with an incidence of 0.44 to 1 per 1000 live births. Following the failed closure in MMC, agenesis of fetal vertebral arches leads to a protrusion of spinal cord, nerve roots, and meninges in a sac that protrudes through the skin of the lumbar area (Figs 1a and 1b). In surviving individuals with MMC, disruption of the cord at the affected area leads to a lifetime of facing incontinence, numbness, and abnormalities of the lower extremities. The exposed nature of the sac leads to greatly increased risk of infection in the neonatal period.3

The factors affecting neural tube closure are varied and complex. Genetic influences during early fetal development play an integral part in neural migration, especially epigenetic regulation through DNA methylation and histone modifications. Some trisomies (3, 8, X) are linked to NTDs, without specific causative genetic links identified yet.4 Environmental factors are also commonly cited as modifiers of these epigenetic processes and the transcriptional processes they drive. Folate antagonist medications such as methotrexate and valproic acid increase rates of NTDs 6-fold.2,5 Folic acid supplementation has been linked to significantly decreased NTD occurrence. Maternal obesity and diabetes have also been implicated as risk factors for NTDs due to alterations in genes associated with glucose metabolism.2 Interestingly, factors such as smoking and drug use have not shown significant association.5

Soft-tissue coverage provides structural support to the neurosurgical dural repair, which helps avoid cerebrospinal fluid (CSF) leaks. Furthermore, the barrier provided by the soft-tissue flap separates the CSF from the skin, a potential source of meningitis. There are many options for soft-tissue coverage following neurosurgical repair of the MMC. Defects that are too large to be closed by primary closure can be achieved by myocutaneous or fasciocutaneous flaps. Myocutaneous closure has been shown efficacious for repair, utilizing latissimus, gluteal, and paraspinous muscles.6 These muscle flaps are able to fill dead space in larger defects with robust, vascularized tissue. Fascial turnover flap closure using bilateral paraspinous muscle fascia is also widely used and has been shown to provide a strong repair that is well vascularized (Figs 3a, 3b, and 4). These are effective when the defect is caudal to the paraspinous muscles. Paraspinous techniques have also been shown to reduce cord tethering as a complication following repair.7

Figure 3. (a, b) Intraoperative paraspinal turnover flap technique and skin closure. The fascial closure technique (a) adds structural support to the neurosurgical repair, decreasing the risk of cerebrospinal fluid leak and infection. Three-sided skin closure (b) was formed without removal of redundant tissue.
Figure 4. Postoperative photograph taken 2 months following closure.


1. Sadler TW. Embryology of neural tube development. Am J Med Genet C Semin Med Genet. 2005;135C(1):2-8. doi:10.1002/ajmg.c.30049.

2. Wilde JJ, Petersen JR, Niswander L. Genetic, epigenetic, and environmental contributions to neural tube closure. Annu Rev Genet. 2014;48:583-611. doi:10.1146/annurev-genet-120213-092208.

3. Northrup H, Volcik KA. Spina bifida and other neural tube defects. Curr Probl Pediatr. 2000;30(10):317-32.

4. Goetzinger KR, Stamilio DM, Dicke JM, Macones GA, Odibo AO. Evaluating the incidence and likelihood ratios for chromosomal abnormalities in fetuses with common central nervous system malformations. Obstet Gynecol. 2008;199(3):285. e1-285.e6.

5. Detrait ER, George TM, Etchevers HC, Gilbert JR, Vekemans M, Speer MC. Human neural tube defects: developmental biology, epidemiology, and genetics. Neurotoxicol Teratol. 2005;27(3):515-24.

6. Kobraei EM, Ricci JA, Vasconez HC, Rinker BD. A comparison of techniques for myelomeningocele defect closure in the neonatal period. Childs Nerv Syst. 2014;30(9):1535-41.

7. Patel KB, Taghinia AH, Proctor MR, Warf BC, Greene AK. Extradural myelomeningocele reconstruction using local turnover fascial flaps and midline linear skin closure. J Plast Reconstr Aesthet Surg. 2012;65(11):1569-72.

Journal ID: ePlasty Volume: 16
ISSN: 1937-5719 E-location ID: ic51
Publisher: Open Science Company, LLC Published: December 27, 2016

Add this page to your favorite Social Bookmarking websites
Digg! yahoobuzz! StumbleUpon! Reddit! Technorati!! Mixx! Free and Open Source Software News Google! Live! Facebook! Yahoo! Joomla Free PHP